Appeal No. 2005-2739 Page 5 Application No. 09/966,893 specification satisfies the requirement is a question of fact, which must be resolved on a case-by case basis (Vas-Cath, 935 F.2d at 1562-63, 19 USPQ2d at 1116), and it is the examiner’s “initial burden [to] present[ ] evidence or reasons why persons skilled in the art would not recognize in the disclosure a description of the invention defined by the claims” (In re Wertheim, 541 F.2d 257, 263, 191 USPQ 90, 97 (CCPA 1976)). “Applicants have some flexibility in the ‘mode selected for compliance’ with the written description requirement” (University of Rochester, 358 F.3d at 928, 69 USPQ2d at 1896), and it is well settled that actual reduction to practice is not necessary to satisfy the requirement (id. at 926, 69 USPQ2d at 1894). Finally, the court has made it clear that other factors, including the level of skill in the art, are relevant to whether a description satisfies § 112. See Capon v. Eshhar, 418 F.3d 1349, 1358-59, 76 USPQ2d 1078, 1085 (Fed. Cir. 2005) (“[T]he determination of what is needed to support generic claims to biological subject matter depends on a variety of factors, such as the existing knowledge in the particular field, the extent and content of the prior art, the maturity of the science or technology, the predictability of the aspect at issue, and other considerations appropriate to the subject matter.”). Appellants point out that the claims “encompass only those proteins useful for treating lysosomal storage disorders [ ] other than Fabry disease” and “[a] comprehensive list of such proteins is provided in Table 1 of the specification” (Appeal Brief, page 7), together with “references to scientific literature and/or Genbank accession numbers disclosing the structure (amino acid sequence) of these proteins” (id., page 5). Appellants argue that “[t]his structural information can be used to create nucleic acid vectors for the expression of these proteins in any desired cell type, including insectPage: Previous 1 2 3 4 5 6 7 8 9 10 11 NextLast modified: November 3, 2007